Skip to content
orbyd

Dossier · QBTS · Watchlist

QBTS · D-Wave Quantum Inc. · Stock research

LOW Retail squeeze Catalyst · quantum-computing

Last analysed ·

Current thesis

The policy leg is done: QBTS lost the $20 shelf on 2026-07-13 and sits near $16.70, -29.4% MTD and ~64% off the $46.75 high, with the whole quantum cohort printing lower lows and inverse quantum ETFs up to +108%. Sell-side still carries a $37.39 average target into a $12.4M TTM revenue base. Stand aside; the 2026-08-06 Q2 print is the next real information event.

Invalidation trigger

A weekly close below $12.75 breaks the 52-week floor and confirms the theme has moved from correction to full unwind, voiding any re-accumulation read. Secondary: the 2026-08-06 Q2 print showing revenue below Q1's $2.86M, or a new ATM/shelf take-down beyond the $100M Commerce issuance.

Thesis status

Open commitment catalyst in 18dscored if the trigger above fires How this is scored →

Latest analysis and events for QBTS —

As of 2026-04-22, orbyd's latest analysis for D-Wave Quantum Inc. (QBTS): 6 sessions post-squeeze watching for first daily higher-low to confirm re-accumulation vs. distribution.

Invalidation trigger: A weekly close below $12.75 breaks the 52-week floor and confirms the theme has moved from correction to full unwind, voiding any re-accumulation read. Secondary: the 2026-08-06 Q2 print showing revenue below Q1's $2.86M, or a new ATM/shelf take-down beyond the $100M Commerce issuance.

Next dated event on file: — catalyst in 18d.

Current Thesis

The federal-sponsorship leg that carried this name from May into late June has been fully round-tripped. QBTS traded near $16.70 on 2026-07-18, down 29.4% month-to-date and roughly 64% below the $46.75 52-week high, after losing the $20 shelf on 2026-07-13 the same shelf that framed the 2026-05-21 government-stake gap. The move was not idiosyncratic: IonQ fell 34.1% in July, Rigetti 27%, and Quantum Computing Inc. Traded down with them on 2026-07-13 with no company news anywhere in the group. Inverse single-stock quantum ETFs (IONZ, QBTZ, RGTZ) printed gains up to 108% by 2026-07-17. A theme that spawns five new 2X leveraged ETFs on 2026-07-01 and inverse products topping the leaderboard sixteen days later has completed its retail cycle. What remains is a $6.2B market cap against $12.44M of trailing revenue that shrank 41.8% year-over-year, and a sell-side consensus of $37.39 — that has not marked to the tape. The next dated information event is the 2026-08-06 Q2 print. Until then this is a broken structure looking for a floor, and the burden of proof sits with the buyer.

Bullish and bearish views on D-Wave Quantum Inc.

The model's bull view on D-Wave Quantum Inc. (QBTS), in brief: Cash runway intact: ~$588M cash reported at the Q1 print (2026-05-12) against ~$355M of 2025 losses removes the immediate forced-financing gun that historically defined the bottom of prior fade cycles in this name. The bear view: The structure has broken, not corrected: the $20 level that defined the 2026-05-21 gap base gave way on 2026-07-13, filling the entire government-stake move. Both cases follow in full.

Bull Case

  • Cash runway intact: ~$588M cash reported at the Q1 print (2026-05-12) against ~$355M of 2025 losses removes the immediate forced-financing gun that historically defined the bottom of prior fade cycles in this name.
  • Bookings inflection is real: Q1 2026 bookings of $33.4M, +1,994% YoY, is the one line in the model that argues commercial traction rather than pure narrative.
  • Policy sponsorship is durable, not a one-day headline: two quantum executive orders signed 2026-06-23, the $100M CHIPS stake (2026-05-21), and a ~$1.6M NSF grant via the National Quantum Virtual Laboratory program (2026-06-30) establish D-Wave as a named participant in a federal program Google publicly declined to join on the government's terms (2026-06-12).
  • Third-party validation: named one of only two "Leaders" in IDC's 2026 quantum computing assessment the kind of institutional stamp that supports enterprise procurement cycles.
  • Roadmap widening past annealing: launch of a gate-model quantum simulator with error-aware programming plus a refreshed technology roadmap (2026-06-18) removes the single-architecture objection that has capped the multiple versus IonQ.
  • Analyst floor far above spot: 14 analysts at Strong Buy, average target $37.39, including Mizuho Outperform $35 (2026-06-15) and a cluster of $40 Buys (2026-06-02).
  • Washington visibility continues: D-Wave featured alongside Nvidia, IBM, Rigetti and Infleqtion at the 2026-07-14 quantum industry showcase on Capitol Hill.

Bear Case

  • The structure has broken, not corrected: the $20 level that defined the 2026-05-21 gap base gave way on 2026-07-13, filling the entire government-stake move. Price now trades below every meaningful moving average with the 50-day beneath the 200-day.
  • Revenue is going backwards: TTM revenue of $12.44M is down 41.8% YoY, and Q1 2026 revenue of $2.86M missed the ~$4.22M consensus (2026-05-12). At a $6.2B market cap that is roughly 500x sales with a shrinking numerator.
  • Losses are widening: net income of -$368M and EPS of -$1.08 TTM against 370.45M shares outstanding. Every quarter of that burn is a future share-count event.
  • The $100M CHIPS award is an LOI, not a definitive agreement (2026-05-21). The stock issued to Commerce lands only on final documentation and is milestone- and appropriations-contingent, which makes it dilution overhang before it is validation.
  • Sell-side is stranded above the tape: an average target of $37.39 versus ~$16.70 spot means analysts upgraded into the top and have not cut. Targets lagging price downward is a mechanical fade risk each time one is revised.
  • Macro is hostile to this exact cohort: the 2026-07-13 unwind traced to Nasdaq-100 weakness (-1.48% intraday), Strait of Hormuz tension, an oil spike, and repricing of expensive technology. Names with no earnings support get sold first in that regime and QBTS carries -$1.14 TTM EPS.
  • Product-cycle saturation confirmed: five 2X leveraged quantum ETFs launched 2026-07-01 into the top; inverse versions were the sector's best performers by 2026-07-17.

Setup & Price Structure

Spot near $16.70 (2026-07-18), 52-week range $12.75–$46.75, market cap $6.20B. The stock lost $20 on 2026-07-13 and traded as low as the $18.85 area intraday that session before continuing lower through the week. The prior structural base the 2026-05-21 government-stake gap has been filled, which removes the last piece of the policy-leg architecture. The 50-day sits below the 200-day and both slope down. The next visible demand shelf is the 52-week low at $12.75, roughly 24% below spot, with nothing structural in between. Volume through the July decline has been expansionary on down days, which is distribution rather than a shakeout. Any constructive read requires a daily higher-low that holds, followed by a reclaim of $20 on expanding volume a two-step repair that has not begun. Buying a 29% monthly decline in a name with 500x sales and no earnings floor is the mechanic that ends accounts in this archetype; the correct stance is to let the cohort find a level first.

Catalyst Calendar (next 30 days)

  • 2026-07-24 NYSE → Nasdaq listing transfer becomes effective (announced 2026-07-14). Mechanical; watch for index and ETF rebalance flow around the switch, which can produce a one-to-two-session volume distortion unrelated to fundamentals.
  • 2026-08-06 (after close, confirmed) Q2 2026 earnings. The binary. Consensus will anchor on whether revenue recovers above Q1's $2.86M and whether the $33.4M bookings figure converts. A second consecutive miss against a $6.2B cap has significant downside asymmetry.
  • Ongoing, undated final documentation on the $100M Commerce/CHIPS agreement. Signature triggers the share issuance; continued silence extends the overhang.
  • Ongoing, undated sell-side target revisions. With consensus at $37.39 and spot at $16.70, downward marks are more likely than upgrades and each one is a headline risk.

What Would Change Our Mind

The bearish read on entry quality would need a genuine repair sequence, not a bounce. Concretely: a daily higher-low that holds above the $12.75–$14 zone, followed by a weekly close back above $20 on volume exceeding the July distribution days, would re-establish the base that broke on 2026-07-13. Separately, a Q2 print on 2026-08-06 showing revenue above $5M with bookings holding near the $33.4M run-rate would put an earnings floor under a story that currently has none, and would justify revisiting the name on the first pullback rather than the first pop. Execution of the $100M Commerce agreement into definitive documents would convert the largest overhang into a funded catalyst. Absent those, further weakness is trend, not opportunity, and the temptation to add size on the way down is the specific error this archetype punishes hardest.

Correlation Notes

QBTS trades as a component of a tightly correlated basket IONQ, RGTI, QUBT, with QTUM as the sector proxy and the correlation tightens on down days. The 2026-07-13 session had all four falling 6–8% simultaneously on zero company-specific news, which is the defining behaviour of the group. Any sizing decision must account for total quantum exposure, since a basket of four names here is one position with four tickers. Beyond the cohort, the name carries high beta to long-duration technology and to the Nasdaq-100 broadly; the July drawdown coincided with risk-off driven by Strait of Hormuz tension and an oil move higher. Second-order links run to the broader speculative-growth complex rather than to semiconductor fundamentals QBTS does not trade with Nvidia's earnings, it trades with retail risk appetite. The inverse ETF complex (IONZ, QBTZ, RGTZ) now offers a direct short expression, which adds a mechanical seller during declines that did not exist in prior cycles.

Notes

  • 2026-04-18: seed: Serenity/attention list
  • retail squeeze → hard 1%/name sizing cap on any entry
  • Never average down if stopped
  • re-enter only on fresh higher-low setup
  • Q1 2026 earnings ~May 12–15 est. (IR date unconfirmed as of 2026-04-19) defer/skip if ≤3 trading days pre-print
  • Group trades as correlated basket (QBTS/IONQ/RGTI/QUBT) size with basket exposure in mind
  • Historical pattern: post-squeeze fades 40–60% into next ATM raise
  • Never average down if stopped
  • re-enter only on fresh higher-low setup
  • Q1 2026 earnings ~May 12–15 est. (IR date unconfirmed as of 2026-04-22) defer/skip if ≤3 trading days pre-print
  • 2026-04-22: 6 sessions post-squeeze watching for first daily higher-low to confirm re-accumulation vs. distribution
  • No price feed available 2026-04-22 dossier logic only; block entry until tape is visible
  • retail squeeze → HARD 1%/name sizing cap on ANY entry. The government-stake/sovereign-compute narrative does NOT relax this; trading behavior is still pure basket-beta retail reflexivity.
  • Never average down if stopped, re-enter ONLY on a fresh daily higher-low that holds the May-21 gap base with volume re-expansion.
  • Group as a correlated basket (QBTS/IONQ/RGTI/QUBT/QTUM) size with TOTAL quantum exposure in mind; the whole cohort moved together on the 5/21 $2B bet and is cooling together (5/26).
  • SELL-SIDE HAS CAUGHT UP: B. Riley/Roth/Needham all to $40 on 6/2. Per playbook, sell-side upgrading = LATE, not early. The 3-6-week-ahead edge window is closed on this leg.
  • $100M CHIPS award is an LOI, NOT a definitive agreement (5/21). $100M of new stock to Commerce only issues on final docs milestone- and appropriations-contingent. Validation + dilution overhang, not cash-in-hand.
  • Balance sheet bear case softened: Q1 (5/12) showed $588M cash, so near-term forced-ATM pressure is LOWER than the old dossier assumed but ~$355M TTM losses still burn it and a raise into strength is the classic a6 top-tell.
  • Q1 2026 (5/12): revenue $2.86M MISS vs $4.22M consensus; bookings $33.4M (+1,994% YoY) incl $20M FAU + $10M Fortune-100 QCaaS. Revenue line is lumpy/unmodellable reaction is pure sentiment.
  • Next earnings ~August 2026 (Q2). NO earnings blackout in the next-30d window binary-print risk is OFF the table until then.
  • Distribution tells active: VP Sophie Ames sold $437K (5/22), CFO sold >10K shares; short interest ~14% of shares / ~16% float and JUMPING on valuation concerns (5/23).
  • Helium-shortage production risk flagged in Q1 commentary execution wildcard for the 100k-qubit annealing build and the 2032 roadmap (Investor Day 6/1).
  • Quantinuum IPO (~$14.3B target, 6/3) is a sector top-tell: more quantum equity supply + a direct higher-quality competitor that could 'eat their lunch'. Watch as a basket-wide catalyst.
  • a6 trim discipline: RSI>82 auto-trims from rule layer; don't override. RSI>75 is a review flag, not an auto-exit. This is fresh-entry conviction only.
  • retail squeeze → HARD 1%/name sizing cap on ANY entry; the sovereign-compute narrative does not relax it behavior is basket-beta retail reflexivity.
  • Never average down re-enter only on a fresh daily higher-low that holds the May-21 gap base with volume re-expansion.
  • Size against TOTAL quantum basket exposure (QBTS/IONQ/RGTI/QUBT/QTUM); the cohort moved together on the 5/21 $2B bet and is cooling together.
  • Sell-side caught up: B. Riley/Roth/Needham all $40 on 6/2 per playbook, clustered upgrades = LATE; the 3-6-week-ahead edge window on this leg is closed.
  • $100M Commerce award is an LOI, not a definitive agreement (5/21); $100M of new stock issues only on final, appropriations-contingent docs dilution overhang.
  • Q1 (5/12) showed ~$588M cash, softening the forced-ATM bear case; ~$355M TTM losses still burn it.
  • Q2 2026 earnings ~mid-August (est., unconfirmed) defer/skip if an entry sets up within 3 trading days pre-print.
  • Quantinuum ($14.3B IPO 6/3) is now a better-capitalized direct comparable; its 6/4 day-two fade is a basket sentiment read.
  • Archetype: retail squeeze hard 1%/name sizing cap on any entry. The sovereign-compute / executive-order narrative does NOT relax this; behavior is still pure basket-beta retail reflexivity.
  • Never average down if a probe is stopped, re-enter only on a fresh daily higher-low that holds the breakout retest with volume re-expansion.
  • Group as a correlated basket (QBTS/IONQ/RGTI/QUBT/QTUM) size with TOTAL quantum exposure in mind; the cohort moved together on the 6/23 executive orders and will roll together.
  • Cleaner entry is a pullback that holds the breakout retest (mid-$20s) than a chase into the post-6/23 policy pop; current price is stretched after +35% off the CHIPS base.
  • Q2 2026 earnings ~mid-August 2026 (est., IR date unconfirmed) defer/skip if ≤3 trading days pre-print.
  • Sell-side has caught up: Mizuho $35 (6/15) after triple $40 PTs (6/2). Per playbook, broad sell-side upgrades = late, not early; the 3-6-week-ahead edge on the government leg closed weeks ago.
  • $100M Commerce award is stock issuance contingent on final, appropriations-dependent docs validation plus dilution overhang, not cash-in-hand.
  • Retail squeeze → hard 1%/name sizing cap on ANY entry; the government-stake/sovereign-compute narrative does NOT relax it behavior is still pure basket-beta retail reflexivity.
  • Never average down; re-enter ONLY on a fresh daily higher-low that holds the 2026-05-21 gap base near $20 with volume re-expansion.
  • Group as a correlated basket (QBTS/IONQ/RGTI/QUBT/QTUM) size with TOTAL quantum exposure in mind; the whole cohort moves together on policy headlines.
  • Sell-side has caught up: Mizuho $35 (6/15), triple $40 Buys (6/2). Per playbook, sell-side upgrading = LATE the 3-6-week early-edge window on the government narrative is closed.
  • $100M CHIPS award is an LOI, NOT a definitive agreement (5/21); the new stock to Commerce issues only on final, milestone- and appropriations-contingent docs → dilution overhang, not cash-in-hand.
  • Q2 2026 earnings ~mid-August (est., IR date unconfirmed) avoid fresh entries within 3 trading days of the print.
  • Historical pattern: post-squeeze fades 40–60% into the next ATM raise; a raise-into-strength 8-K is the signature top-tell for this name.
  • 2026-07-01 Tradr launched five 2X leveraged single-stock quantum ETFs treat leveraged-product proliferation as a late-cycle saturation signal, not a demand confirmation.
  • Retail-squeeze behaviour → hard 1%/name sizing cap on any entry. Government-stake and executive-order narratives do NOT relax this; the tape is basket-beta reflexivity.
  • Never average down. Re-entry only on a fresh daily higher-low with volume re-expansion above a reclaimed $20 shelf.
  • Group as a correlated basket (QBTS/IONQ/RGTI/QUBT/QTUM) size on TOTAL quantum exposure. The cohort moved up together on the 5/21 and 6/23 policy events and is unwinding together in July.
  • Q2 2026 earnings CONFIRMED 2026-08-06, after close. Avoid fresh entries inside 3 trading days of the print.
  • NYSE → Nasdaq listing transfer effective 2026-07-24. Mechanical, not fundamental; watch for index/ETF rebalance flow around the switch.
  • Sell-side is stale-long: 14 Strong Buy, avg PT $37.39 vs ~$16.70 spot. Analyst catch-up already happened on the way up (Mizuho $35 6/15, triple $40 6/2) targets lagging price down is a fade signal, not support.
  • $100M CHIPS award is an LOI, not a definitive agreement (5/21). Stock to Commerce issues only on final docs milestone- and appropriations-contingent dilution overhang.
  • Fundamental gap is extreme: TTM revenue $12.44M (-41.8%), net income -$368M, ~$6.2B market cap = ~500x sales. Nothing in the numbers cushions a de-rate.
  • Prior structural marker: the $20 level defined the 2026-05-21 government-stake gap base. It broke 2026-07-13 treat any move back above it as the first repair condition, not as confirmation on its own.

Related · shared themes

IONQ

IonQ, Inc.

The gov-capital quantum leg has broken. IONQ lost the $44 spring base and then $40, is on a seven-week losing streak and ~36% off its June level, as Wolfpack's Pentagon-earmark thesis reasserted and Morgan Stanley cut its stake below 5%. Inverse quantum ETFs up to +108% mark an active unwind into an unconfirmed early-August Q2 print. No entry here.

LOW

QUBT

Quantum Computing Inc.

The $10 shelf broke: QUBT closed $7.80 on 2026-07-17, market cap down to ~$1.76B on $4.33M TTM revenue, while the quantum basket de-rated on a risk-off tape. Early-July authorization to 450M shares plus a $118.52M/13.54M-share registration re-arms the dilution engine into a downtrend. No trend to buy ahead of the 2026-08-13 Q2 print.

LOW

RGTI

Rigetti Computing, Inc.

Quantum pure-play basket is in outright hype-cycle deflation: RGTI ~$14.19 (2026-07-17), -27% MoM, and the $14 shelf that held the May CHIPS-stake gap and the June executive-order pop has broken. Inverse quantum ETFs printing +108% and the Quantinuum IPO landing into the tape mark late-cycle supply. No company binary until the Q2 print ~2026-08-10. Avoid fresh entries.

LOW

QUIK

QuickLogic Corporation

The eFPGA/defense royalty squeeze has fully unwound: QUIK is ~$13, roughly 47% below the $24.33 June high, and the $18 shelf broke exactly as the Russell inclusion passed. July's post-quantum IP announcement drew no bid good news into no demand. Broken tape; the read now hinges on the ~2026-08-11 Q2 print, not the story.

LOW

See also · stocks to watch

quantum computing stocks to watch